Judges Scientific plc (LON:JDG - Get Free Report) insider Susan Nyman purchased 120 shares of the company's stock in a transaction dated Thursday, May 7th. The stock was purchased at an average price of GBX 4,880 per share, for a total transaction of £5,856.
Judges Scientific Stock Performance
Shares of JDG stock traded up GBX 92.20 on Friday, reaching GBX 4,912. The stock had a trading volume of 16,282 shares, compared to its average volume of 24,239. The stock has a market cap of £327.14 million, a P/E ratio of 60.34, a price-to-earnings-growth ratio of 0.56 and a beta of 0.76. Judges Scientific plc has a 1 year low of GBX 3,480 and a 1 year high of GBX 9,120. The company has a debt-to-equity ratio of 77.90, a quick ratio of 0.65 and a current ratio of 2.39. The company has a 50 day simple moving average of GBX 4,331.74 and a 200 day simple moving average of GBX 5,028.54.
Judges Scientific (LON:JDG - Get Free Report) last released its quarterly earnings results on Tuesday, March 31st. The company reported GBX 275.30 earnings per share (EPS) for the quarter. The firm had revenue of £145.80 million for the quarter. Judges Scientific had a return on equity of 6.24% and a net margin of 3.77%. Equities research analysts expect that Judges Scientific plc will post 402.5824271 EPS for the current year.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on JDG. Berenberg Bank reiterated a "buy" rating and set a GBX 5,600 target price on shares of Judges Scientific in a research report on Tuesday, March 31st. Shore Capital Group reissued a "house stock" rating on shares of Judges Scientific in a research note on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of GBX 6,490.
Get Our Latest Research Report on Judges Scientific
About Judges Scientific
(
Get Free Report)
Judges Scientific plc AIM: JDG, is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Judges Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Judges Scientific wasn't on the list.
While Judges Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
